🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Adolfo Aleman

Medical Oncology Hematology Consultants

ORCID: 0000-0002-8884-2100

Also affiliated with Tisch Hospital, Hackensack Meridian Health, Icahn School of Medicine at Mount Sinai

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients”.

Augmentation of humoral and cellular immune responses after third-dose SARS-CoV-2 vaccination and viral neutralization in myeloma patients

Cancer Cell(2022)10.1016/j.ccell.2022.03.013

N/A

2.1DataRank · unranked

38 citations

Oliver Van Oekelen, Bhaskar Upadhyaya, Katherine F. Beach, Ariel Kogan Zajdman, Hala Alshammary +43 more

Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma

Cancer Cell(2021)10.1016/j.ccell.2021.06.014

N/A

0.808DataRank · unranked

218 citations

Charles Gleason, Sarita Agte, Komal Srivastava, Katherine F. Beach, Adolfo Aleman +27 more

Variable cellular responses to SARS-CoV-2 in fully vaccinated patients with multiple myeloma

Cancer Cell(2021)10.1016/j.ccell.2021.09.015

N/A

0.654DataRank · unranked

77 citations

Bhaskar Upadhyaya, Kevin Tuballes, Katerina Kappes, Charles Gleason, Katherine F. Beach +37 more

Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma

EBioMedicine(2023)10.1016/j.ebiom.2023.104886

N/A

0.385DataRank · unranked

12 citations

Morgan van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Christian Cognigni, Jacob Mischka +43 more

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008110

N/A

0.309DataRank · unranked

5 citations

Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal +8 more

Fatal breakthrough infection after anti-BCMA CAR-T therapy highlights suboptimal immune response to SARS-CoV-2 vaccination in myeloma patients

medRxiv(2021)10.1101/2021.05.15.21256814

N/A

0.269DataRank · unranked

5 citations

Oliver Van Oekelen, Bhaskar Upadhyaya, Sarita Agte, Katerina Kappes, Katherine F. Beach +29 more

Clonal Hematopoiesis and Inflammation Predict Hematologic Toxicity and Secondary Myeloid Malignancies after B-Cell Maturation Antigen–Directed Chimeric Antigen Receptor T-cell Therapy

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-1587

N/A

0DataRank · unranked

18 citations

Jerrel L. Catlett, Saoirse Bodnar, Darren Pan, Adolfo Aleman, Taotao Sheng +15 more

A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurements

Communications Biology(2022)10.1038/s42003-022-04270-3

N/A

0DataRank · unranked

8 citations

Mark M. Stevens, Selim Olçum, Anthony Minnah, Madeleine Vacha, Rachel LaBella +17 more